(Q41500358)

1 October 2017

title

Osmotic stress mimics effects of vasopressin on learned behaviour (English)

1 reference

1 October 2017

0 references

Koob GF

1

1 reference

1 October 2017

Dantzer R

2

1 reference

1 October 2017

Rodriguez F

3

1 reference

1 October 2017

Bloom FE

4

1 reference

1 October 2017

Le Moal M

5

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 June 1985

1 reference

1 October 2017

1 reference

1 October 2017

volume

315

1 reference

1 October 2017

issue

6022

1 reference

1 October 2017

page(s)

750-752

1 reference

https://scigraph.springernature.com/pub.10.1038/315750a0

1 October 2017

exact match

0 references

cites work

The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat

1 reference

Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat

21 January 2018

1 reference

Modification of conditioned behavior of rats by neurohypophyseal hormones and analogues

21 January 2018

1 reference

7 January 2021

Arginine vasopressin and a vasopressin antagonist peptide: opposite effects on extinction of active avoidance in rats.

1 reference

7 January 2021

Effects of vasopressin on active and passive avoidance behavior

1 reference

7 January 2021

Oxytocin, vasopressin and memory: opposite effects on consolidation and retrieval processes

1 reference

7 January 2021

Antagonism of effects of vasopressin (AVP) on inhibitory avoidance by a vasopressin antagonist peptide [dPtyr(Me)AVP].

1 reference

7 January 2021

Effects of vasopressin on human memory functions.

1 reference

7 January 2021

Abnormalities in plasma and cerebrospinal-fluid arginine vasopressin in patients with anorexia nervosa

1 reference

7 January 2021

A critique of the vasopressin-memory hypothesis

1 reference

7 January 2021

Vasopressor receptor antagonist prevents behavioural effects of vasopressin

1 reference

7 January 2021

Behavioral effects of neuropeptides: endorphins and vasopressin

1 reference

7 January 2021

Vasopressin potentiation in the performance of a learned appetitive task: reversal by a pressor antagonist analog of vasopressin.

1 reference

7 January 2021

Can aversive properties of (peripherally-injected) vasopressin account for its putative role in memory?

1 reference

7 January 2021

Design of potent antagonists of the vasopressor response to arginine-vasopressin

1 reference

7 January 2021

The effect of transection and cold block of the spinal cord on synaptic transmission between Ia afferents and motoneurones

1 reference

7 January 2021

The Role of Blood Osmolality and Volume in Regulating Vasopressin Secretion in the Rat

1 reference

7 January 2021

Destruction of the locus coeruleus or the dorsal NE bundle does not alter the release of punished responding by ethanol and chlordiazepoxide

1 reference

7 January 2021

Can neurohypophysial hormones cross the blood-cerebrospinal fluid barrier?

1 reference

7 January 2021

Vasopressin Exhibits a Rhythmic Daily Pattern in Cerebrospinal Fluid But Not in Blood

1 reference

7 January 2021

Neuroendocrinology of Cerebrospinal Fluid: Peptides, Steroids, and Other Hormones

1 reference

7 January 2021

Neuropeptides and the Blood-Brain Barrier

1 reference

7 January 2021

A Major Metabolite of Arginine Vasopressin in the Brain Is a Highly Potent Neuropeptide

1 reference

7 January 2021

Central target for the behavioural effects of vasopressin neuropeptides

1 reference

7 January 2021

Intracerebroventricular application of a vasopressin antagonist peptide prevents the behavioral actions of vasopressin

1 reference

7 January 2021

Neuropeptides: do they integrate body and brain?

1 reference

7 January 2021

Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system

1 reference

7 January 2021

Identifiers

DOI

10.1038/315750A0

1 reference

Dimensions Publication ID

1 October 2017

1017104740

0 references

1 reference